Rapid mAb Discovery against Cell Surface Receptor Based on B cell Screening on Adherent Cell Lines

Abstract: Advanced high-resolution single B cell screening for rapid antibody discovery using the Beacon platform. Just 29 DAYS from immunization to sequence for a cell surface target.

Covered in this Case Study

Goal: delivery of a diverse panel of IgG and scFv anti-Target X binders

The partner had previously attempted in vivo discovery in house and suspected the immunogen to be poorly immunogenic

Successful antibody discovery campaign against a known poorly-immunogenic cell surface target

Share your details to Get the Case Study

Genes

Oligo Pools

NGS Target Enrichment Solutions

Variant Libraries

Synthetic Controls

Antibody Discovery

Rapid mAb Discovery against Cell Surface Receptor Based on B cell Screening on Adherent Cell Lines

Related Resources

Anti-Idiotypic Antibody Discovery Service Sheet

Identifying Specific mAb Binders to a CAR, Enabling Drug Quantification in Patient Serum Sample

Ultrafast, Single B Cell-based Anti-idiotypic mAb Discovery Against a mAb Therapeutic